CICATRIDINA

CICATRIDINA OINTMENT 60 G

CICATRIDINA OINTMENT 60 G

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

Cicatridine

ointment

Description
CE Medical Device (EU Reg. 2017/745) Class IIb.
Adjuvant treatment of repair processes in case of:
- irritation and redness, even following peeling, hair removal and laser procedures;
- superficial lesions: cracks, scratches, abrasions, erythema, first and second degree burns, superficial cuts;
- deep lesions: surgical wounds, bedsores, ulcers.
It exerts its action thanks to the presence of hyaluronic acid, a mucopolysaccharide abundantly distributed in many body tissues. Hyaluronic acid, thanks to its ability to retain water, forms a film that hydrates, accelerates, and improves the process of tissue re-epithelialization and repair.

How to use
Wash your hands before and after using the medical device.
We recommend thoroughly cleaning the area to be treated before each application.
Break the seal of the tube using the back of the cap. Dispense an appropriate amount of product based on the area to be treated and apply with a gentle massage. If necessary, protect with gauze. Reseal the tube with the cap.

Adults and children: apply 2-3 times a day or as prescribed by your doctor.
If necessary, CICATRIDINA ointment can be used for prolonged periods, in any case after 30 days of use, stop the treatment and consult your doctor.

Components
Hyaluronic acid sodium salt 0.2%, water, vaseline oil, cetylstearyl alcohol, sweet almond oil, steareth-2, steareth-21, glycerin, sorbitol, silicone oil, chlorhexidine digluconate, imidazolidinyl urea, EDTA disodium salt, BHT.

Warnings
External use.
Keep out of reach of children.
Avoid contact with eyes.
Do not ingest.
If you are pregnant or breastfeeding, as no specific clinical studies have been conducted, consult your doctor before using the device.
Do not use in case of individual hypersensitivity to one of the components of the product.
There are no known interactions with other products, therefore it is advisable to consult your doctor before using CICATRIDINA ointment in combination with other medical devices or topical drugs.
Use, especially if prolonged, of all topical products may cause sensitization. If this occurs, or if other side effects occur, discontinue use and consult your doctor or pharmacist.
After first opening, do not use the product if there are visible signs of degradation such as yellowing or an unpleasant odor.

Conservation
Store tightly closed in a cool, dry place, away from light and heat.
The expiration date refers to the product in its intact packaging, stored properly. Do not use after the expiration date or if the packaging is opened or damaged.
Shelf life of intact packaging: 36 months.

Format
60g tube

Code 1004

CICATRIDINA

CICATRIDINA OINTMENT 60 G

CICATRIDINA OINTMENT 60 G

MINSAN code: 934737394
Previous price: €19,01
Regular price €19,01
Regular price €0,00 Sale price €19,01
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.